Free shipping from CAD $250. 10% off any four items. Ships same day when paid by 3 p.m. on business days. Discreet packaging. Third-party lab reports. Ships from Canada, with Canada Post tracking. For research use only.

TB-500 (Thymosin beta-4): what the research examined

Compound Science

Research Peptide Learning Centre · Published 7 October 2026 · 4 min read

What Thymosin beta-4 (TB-500) is, what the research examined, how to read its certificate, and the research blends that contain it.

TB-500 is the research name for Thymosin beta-4, a naturally occurring peptide studied in cell and animal models of actin regulation and tissue repair. This guide separates what the literature measured from the conclusions a reader might be tempted to add. It is educational and is not a route to personal use or a determination that any activity is permitted.

What Thymosin beta-4 is

Thymosin beta-4 is a 43-amino-acid peptide whose best-characterised biochemical role is binding and sequestering monomeric actin, part of how cells regulate their cytoskeleton. Because actin dynamics underlie cell movement, the peptide is studied in migration and repair models rather than as a single-outcome “recovery” agent. See the TB-500 research profile for the identity recorded on the listing.

What the research examined

A review describes Thymosin beta-4 as an actin-sequestering protein studied for roles in tissue repair (Goldstein et al., 2005). An earlier study reported that it accelerated wound closure in animal models and promoted keratinocyte and endothelial cell migration (Malinda et al., 1999). Read those records directly. They describe defined endpoints in cells and animals; they are not evidence that this material repairs injury or aids recovery in people, and Thymosin beta-4 is not an approved medicine.

Full-length Thymosin beta-4 versus the “fragment”

“TB-500” is used loosely. Some listings describe a short actin-binding fragment; others describe the full 43-amino-acid peptide. The two have different molecular weights, so the distinction matters when matching a material to a method or a report. The Reforge listing is identified as the full Thymosin beta-4 on its certificate of analysis.

Why the form matters in practice: a full 43-amino-acid peptide and a short fragment have different molecular weights, so a method calibrated for one will not report the other correctly, and a certificate written for one identity does not describe the other. This is the main reason to read the identity line on a report rather than relying on the “TB-500” name alone. The guide to lyophilised peptides covers how a vial of this kind is kept and reconstituted once its identity is confirmed.

Reading the TB-500 certificate

This listing’s released batch (TB01) was analysed by Janoshik Analytical at 97.936% peptide purity, with the comment that the purity assessment includes peptide peaks only. A purity figure describes the tested sample; it is not a statement of identity for a different lot, and it does not turn a research material into an authorised medicine. Confirm that any certificate’s material and lot match the inventory in front of you. The COA guide and the Certificate Library explain the report fields.

The research blends that contain TB-500

Thymosin beta-4 also appears as a component of two Reforge research blends: Wolverine (BPC-157 and TB-500) and GLOW (GHK-Cu, BPC-157 and TB-500). A blend combines separately studied materials and does not establish a combined, validated effect; each component keeps its own documentation. A research-use label does not settle regulatory questions; Health Canada’s advisory on online injectable peptides states that research-use wording does not exempt products from regulatory requirements. Read the advisory.

Common questions

Is TB-500 the full peptide or a fragment?

The Reforge listing is identified as the full 43-amino-acid Thymosin beta-4 on its certificate of analysis (batch TB01). The term “TB-500” is used by some suppliers for a shorter fragment, so confirm the identity against the report.

Does the research show TB-500 repairs injuries?

The cited studies report defined endpoints in cells and animal models. They are not evidence that the material repairs injury or aids recovery in people.

Does this listing have a certificate of analysis?

Yes. Batch TB01 was analysed by Janoshik Analytical at 97.936% peptide purity; the certificate is available on the product page.

Why does the full-length versus fragment distinction matter?

The two forms have different molecular weights, so a method or report written for one does not correctly describe the other. Read the identity line on the certificate rather than relying on the name.

Is TB-500 intended for human use?

No. It is presented for laboratory and analytical research only, and this guide is not a treatment or personal-use protocol.

Sources and scope

Published research describes the material and conditions used by its authors. It does not test, certify or endorse Reforge inventory. This guide is educational and is not a treatment or personal-use protocol.